CD44 and neoplasm: This dendrimer was able to downregulate CD44 mRNA and protein expression and inhibit tumor growth without toxicity, suggesting that the targeted delivery of CD44 siRNA along with chemotherapeutic agents may be explored for cancer therapy (104).